AI Engines For more Details: Perplexity Kagi Labs You
Gastrointestinal Health: Clostridium butyricum has been studied for its beneficial effects on gastrointestinal health. It is known to produce butyric acid, a short-chain fatty acid that serves as a major energy source for the cells lining the colon. Butyric acid has been associated with promoting the health and integrity of the intestinal mucosa, regulating inflammation, and supporting the growth of beneficial gut bacteria.
Immune Modulation: Some research suggests that Clostridium butyricum may have immunomodulatory effects, potentially enhancing immune function and helping to regulate immune responses. This could be beneficial for individuals with conditions characterized by immune dysregulation, such as allergies, autoimmune disorders, or inflammatory bowel disease (IBD).
Antimicrobial Activity: Clostridium butyricum has demonstrated antimicrobial activity against certain pathogens, including various bacteria and fungi. By inhibiting the growth of harmful microorganisms, it may contribute to a healthier microbial balance in the gut and help prevent infections.
Antioxidant Properties: Some studies have suggested that Clostridium butyricum may possess antioxidant properties, which could help protect cells and tissues from oxidative damage caused by free radicals. Antioxidants play a role in reducing inflammation and lowering the risk of chronic diseases.
Anti-inflammatory Effects: Butyric acid, produced by Clostridium butyricum, has been shown to have anti-inflammatory effects in the gastrointestinal tract. It can help regulate immune responses and reduce inflammation, potentially benefiting individuals with inflammatory conditions such as IBD or irritable bowel syndrome (IBS).
Potential Therapeutic Applications: Due to its beneficial effects on gut health and immune function, Clostridium butyricum, including formulations like Miyarisan, has been investigated for various therapeutic applications. These may include the management of diarrhea, antibiotic-associated gastrointestinal disturbances, inflammatory disorders, and conditions associated with dysbiosis of the gut microbiota.
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]
